These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7538501)
1. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma. Montemaggi P; Costamagna G; Dobelbower RR; Cellini N; Morganti AG; Mutignani M; Perri V; Brizi G; Marano P Int J Radiat Oncol Biol Phys; 1995 May; 32(2):437-43. PubMed ID: 7538501 [TBL] [Abstract][Full Text] [Related]
2. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation? Montemaggi P; Morganti AG; Dobelbower RR; Brizi G; Smaniotto D; Costamagna G; Cellini N; Marano P Radiology; 1996 Jun; 199(3):861-6. PubMed ID: 8638018 [TBL] [Abstract][Full Text] [Related]
3. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung. Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409 [TBL] [Abstract][Full Text] [Related]
4. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct. Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068 [TBL] [Abstract][Full Text] [Related]
6. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Foo ML; Gunderson LL; Bender CE; Buskirk SJ Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):929-35. PubMed ID: 9369143 [TBL] [Abstract][Full Text] [Related]
7. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma. Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427 [TBL] [Abstract][Full Text] [Related]
8. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Shin HS; Seong J; Kim WC; Lee HS; Moon SR; Lee IJ; Lee KK; Park KR; Suh CO; Kim GE Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):105-12. PubMed ID: 12909222 [TBL] [Abstract][Full Text] [Related]
9. Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma. Lo SS; Wu CW; Chi KH; Tseng HS; Shen KH; Hsieh MC; Lui WY Cancer; 2000 Jul; 89(1):29-34. PubMed ID: 10896997 [TBL] [Abstract][Full Text] [Related]
10. Definitive radiation therapy for extrahepatic bile duct carcinoma. Tsujino K; Landry JC; Smith RG; Keller JW; Williams WH; Davis LW Radiology; 1995 Jul; 196(1):275-80. PubMed ID: 7784581 [TBL] [Abstract][Full Text] [Related]
11. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Kamada T; Saitou H; Takamura A; Nojima T; Okushiba SI Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):767-74. PubMed ID: 8598352 [TBL] [Abstract][Full Text] [Related]
12. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer. Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935 [TBL] [Abstract][Full Text] [Related]
13. Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region. Dvorák J; Petera J; Papík Z; Melichar B; Vanásek T; Hulek P; Jandík P; Mergancová J; Zoul Z; Vacek Z Hepatogastroenterology; 2002; 49(46):1045-7. PubMed ID: 12143198 [TBL] [Abstract][Full Text] [Related]
15. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Buskirk SJ; Gunderson LL; Adson MA; Martinez A; May GR; McIlrath DC; Nagorney DM; Edmundson GK; Bender CE; Martin JK Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2013-23. PubMed ID: 6436203 [TBL] [Abstract][Full Text] [Related]
16. Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report. Macchia G; Costamagna G; Morganti AG; Mutignani M; Giuliante F; Clemente G; Deodato F; Smaniotto D; Mattiucci GC; Sallustio G; Valentini V; Nuzzo G; Cellini N Dig Liver Dis; 2005 Aug; 37(8):615-8. PubMed ID: 15890567 [TBL] [Abstract][Full Text] [Related]
17. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting. Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222 [TBL] [Abstract][Full Text] [Related]
18. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis. Autorino R; Bisiello S; Pappalardi B; Privitera V; Buwenge M; Piccolo F; Masciocchi C; Tagliaferri L; Macchia G; Curti CD; Luppatteli M; Cerrotta A; Morganti AG; Valentini V; Mattiucci G Anticancer Res; 2020 Jun; 40(6):3417-3421. PubMed ID: 32487639 [TBL] [Abstract][Full Text] [Related]
19. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice. Xu X; Li J; Wu J; Zhu R; Ji W Cardiovasc Intervent Radiol; 2018 Feb; 41(2):206-217. PubMed ID: 29075881 [TBL] [Abstract][Full Text] [Related]
20. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas. Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]